Sofiva Genomics Co., Ltd.(TW:6615)
NT$32.50+0.25 (+0.78%)
TW:6615
Sofiva Genomics Co., Ltd. financials statements
NT$32.50
At close:+0.25 (+0.78%)
Sofiva Genomics Co., Ltd. (6615) Income Statement
Sofiva Genomics Co., Ltd. Income Statement
Last quarter (Q2 2026), Sofiva Genomics Co., Ltd.'s total revenue was NT$97.07M, a decrease of 3.59% from the same quarter last year. In Q2, Sofiva Genomics Co., Ltd.'s net income was NT$5.41M. See Sofiva Genomics Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 385.71M | NT$ 453.31M | NT$ 466.80M | NT$ 495.77M | NT$ 508.42M | |
| NT$ 99.13M | NT$ 135.66M | NT$ 129.91M | NT$ 148.99M | NT$ 176.81M | |
| NT$ 132.87M | NT$ 139.03M | NT$ 145.79M | NT$ 145.69M | NT$ 141.71M | |
| Depreciation and Amortization | NT$ 41.60M | NT$ 41.62M | NT$ 41.34M | NT$ 42.79M | NT$ 41.95M |
| NT$ 7.87M | NT$ 66.34M | NT$ 27.86M | NT$ 46.58M | NT$ 77.19M | |
| NT$ -33.74M | NT$ -3.37M | NT$ -15.88M | NT$ 48.35M | NT$ 65.29M | |
| NT$ 25.43M | NT$ 26.99M | NT$ 24.79M | NT$ -1.00M | NT$ -1.60M | |
| NT$ -8.30M | NT$ 23.61M | NT$ 8.90M | NT$ 47.35M | NT$ 63.69M | |
| NT$ -9.36M | NT$ 18.43M | NT$ 11.53M | NT$ 42.78M | NT$ 56.98M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -0.43 | NT$ 0.86 | NT$ 0.54 | NT$ 2.00 | NT$ 2.68 |
| Diluted EPS | NT$ -0.43 | NT$ 0.85 | NT$ 0.54 | NT$ 2.00 | NT$ 2.68 |
| Weighted Average Shares Outstanding | 21.77M | 21.48M | 21.35M | 21.36M | 21.28M |
| Weighted Average Shares Outstanding (Diluted) | 21.77M | 21.64M | 21.37M | 21.38M | 21.29M |
Currency in TWD
